Network and doctors across the country to study incurable diseases.

The 27th , in order to accelerate therapeutic agents making of incurable diseases using iPS cells , Professor Shinya Yamanaka of Kyoto University Center for iPS Cell Research length was set to clear when creating a network and doctors across the country to study incurable diseases . I make full-scale based in new research building to be completed next year .The iPS cells , as well as regenerative medicine to be transplanted is changed to such a tissue of interest , can also be used in drug discovery Find candidate of medicine based on the patient's cells . It is that there are hundreds of incurable disease there is no cure , but the research of drug discovery using iPS cells that is behind Europe and the United States.So , I would like to learn a technique to deal with incurable diseases iPS cell researchers across the country to stay in Kyoto . In addition to research funding in the country , take advantage also research Fund solicited from citizens and patients . Yamanaka said, " compared to regenerative medicine , iPS drug discovery is not much progress . Strongly promoted the research and teachers across the country , want to send the results to patients with serious illnesses who " he said. I want you out some kind of track record as soon as possible regenerative medicine in drug discovery . I will have to think again the awareness of death at the same time . Medicine based on the value of death I might need from medicine you do not let it die 



京都大ｉＰＳ細胞研究所長の山中伸弥教授は２７日、ｉＰＳ細胞を使った難病の治療薬づくりを加速させるため、難病を研究する全国の医師らとネットワークをつくると明らかにした。来年度に完成する新研究棟を拠点に活動を本格化させる。
　ｉＰＳ細胞は、目的の組織などに変化させて移植する再生医療のほか、患者の細胞をもとに薬の候補を探す創薬にも使える。治療法がない難病は数百種類あるとされるが、ｉＰＳ細胞を使った創薬の研究は欧米より遅れているという。
　そこで、全国の難病研究者が京大に滞在してｉＰＳ細胞を扱う技術を学べるようにする。国の研究費に加え、患者や市民らから募った研究基金も活用する。山中さんは「再生医療に比べ、ｉＰＳ創薬はあまり進んでいない。全国の先生たちと研究を強力に進め、難病の患者さんたちに成果を届けたい」と話す。創薬でも再生医療でも早く何らかの実績を出して欲しいですね。同時に死に対する認識を改めて考えなければならないでしょうね。死なせない医学から死の価値に基づく医学が必要なのかもしれませんね。